Drug Duo Approved for Aggressive Thyroid Cancer - HealthDay

Drug Duo Approved for Aggressive Thyroid Cancer HealthDay FRIDAY, May 4, 2018 (HealthDay News) -- Two anti-cancer drugs administered together have been approved by the U.S. Food and Drug Administration to treat an inherited form of thyroid cancer. Tafinlar (dabrafenib) and Mekinist (trametinib) combined have ... and more »

from Health - Google News https://ift.tt/2wfUQcw